Back to search

Article

Eribulin inhibits tumor growth of two novel patient-derived xenograft models of Merkel cell carcinoma

2024-08-13

Abstract excerpt

<title>Abstract</title> <p>Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer with a poor prognosis in advanced cases. While MCC has been reported to be sensitive to chemotherapy and immunotherapy, only about 50% of tumors respond to these treatments. Although developing novel therapeutic strategies against MCC has been desired, few preclinical models, including cell lines and patient-de...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
82f9b901-baa0-57c5-b59e-a8e2f42cdf33
DOI
10.21203/rs.3.rs-4728513/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Eribulin inhibits tumor growth of two novel patient-derived xenograft models of Merkel cell carcinomaDOI 10.21203/rs.3.rs-4728513/v1
Select a neighboring publication to make it the new centre.